Lower-cost alternative to EpiPen OK’d by FDA

(Photo provided by Adamis Pharmaceuticals Corp. shows the Symjepi syringe, prefilled with the hormone epinephrine, which helps stop life-threatening allergic reactions from insect stings and bites or eating foods such as nuts and eggs — AP)
TRENTON, N.J. — U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.
The Food and Drug Administration on Thursday approved Adamis Pharmaceuticals